MNOVNasdaqPharmaceutical PreparationsFiscal year ends December 31
MEDICINOVA INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.40−0.02 (-1.41%)
Close on Oct 19, 2026
- Market cap
- $68.91M
- P/E (TTM)
- –
- Dividend yield
- –
Medicinova statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Medicinova | Industry median |
|---|---|---|
| Market Cap | $68.91M | $197.05M |
| Enterprise Value | $43.49M | $106.56M |
| PS Ratio | 74.86 | 3.93 |
| PB Ratio | 1.85 | 2.14 |
| P/TBV Ratio | 2.49 | 2.46 |
Enterprise value
| Measure | Medicinova | Industry median |
|---|---|---|
| EV / Sales | 47.25 | 2.69 |
Income (trailing twelve months)
| Measure | Medicinova | Industry median |
|---|---|---|
| Revenue | $920.48K | $57.94M |
| Operating Income | -$11.85M | -$21.44M |
| Net Income | -$10.75M | -$22.46M |
| EBITDA | -$11.83M | -$16.91M |
| EPS (Diluted) | -$0.22 | -$0.83 |
Margins
| Measure | Medicinova | Industry median |
|---|---|---|
| Operating Margin | -1287.4% | -44.5% |
| Profit Margin | -1168.2% | -39.2% |
| EBITDA Margin | -1285.3% | -31.3% |
| FCF Margin | -991.2% | -8.85% |
Returns
| Measure | Medicinova | Industry median |
|---|---|---|
| Return on Equity (ROE) | -25.6% | -53.1% |
| Return on Assets (ROA) | -23.8% | -41.0% |
| Return on Invested Capital (ROIC) | -76.6% | -32.0% |
| Return on Capital Employed (ROCE) | -31.6% | -37.8% |
Balance sheet
| Measure | Medicinova | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $25.42M | $62.42M |
| Net Cash (Debt) | $25.42M | $15.68M |
| Net Cash Per Share | $0.52 | $0.65 |
| Equity (Book Value) | $37.27M | $48.79M |
| Book Value Per Share | $0.76 | $1.36 |
| Tangible Book Value | $27.67M | $23.06M |
| Working Capital | $22.96M | $75.77M |
Financial position
| Measure | Medicinova | Industry median |
|---|---|---|
| Current Ratio | 8.75 | 3.30 |
| Quick Ratio | 8.58 | 2.39 |
Cash flow (trailing twelve months)
| Measure | Medicinova | Industry median |
|---|---|---|
| Operating Cash Flow | -$9.11M | -$12.35M |
| Capital Expenditures | -$13.72K | -$1.06M |
| Free Cash Flow | -$9.12M | -$20.28M |
| FCF Per Share | -$0.19 | -$0.41 |
Efficiency
| Measure | Medicinova | Industry median |
|---|---|---|
| Asset Turnover | 0.02 | 0.38 |
| Revenue Per Employee | $153.41K | $398.96K |
| Profits Per Employee | -$1.79M | -$732.08K |
| Employee Count | 6 | 73 |
Dividends and yields
| Measure | Medicinova | Industry median |
|---|---|---|
| Earnings Yield | -15.6% | -21.2% |
| FCF Yield | -13.2% | -7.64% |
Shares
| Measure | Medicinova | Industry median |
|---|---|---|
| Shares Outstanding | 49,221,200 | 59,128,900 |
| Shares Change (YoY) | 0.21% | 11.1% |
| Shares Change (QoQ) | 0.00% | 0.54% |
| Float | 42,944,300 | 48,744,500 |
| Shares Held by Insiders | 12.8% | 11.8% |
| Shares Held by Institutions | 10.5% | 59.4% |
Scores
| Measure | Medicinova | Industry median |
|---|---|---|
| Altman Z-Score | -2.55 | 0.10 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from Medicinova's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.